Japan Expands Crackdown on Misuse of Trial Data; Pfizer Confirms It Faces Probe

Drug Industry Daily
Japanese authorities Friday launched an investigation into claims that falsified clinical trial data was used in an Alzheimer’s study involving several major drugmakers, marking an expansion of the country’s scrutiny of trial data misuse.

To View This Article:


Subscribe To Drug Industry Daily